PROM1 and glioblastoma: This conclusion is supported by the apparent POL5551-induced decrease of nestin positive stem cells in vivo, and additionally by the reduction of the CD133 positive cell fraction in three independent primary GBM isolates by POL5551 in our in vitro studies.